Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT05846880

Recruiting

VitD3 Supplementation in Patients With Multiple Myeloma

Multiple Myeloma
NCT05495620

Not yet recruiting

Long-term KRd in Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma in Relapse | Multiple Myeloma, Refractory
NCT04924647

Recruiting

Lenalidomide and Dexamethasone for Rosai-Dorfman Disease

Rosai-Dorfman Disease
NCT03413800

Completed

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Multiple Myeloma | Relapsed Hematologic Malignancy
NCT04504318

Completed

Apixaban vs Enoxaparin Following Microsurgical Breast Reconstruction-An RCT

Venous Thromboembolism
NCT02076009

Completed

A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Multiple Myeloma
NCT04634799

Suspended

Study to AntagOnize Plasminogen Activator Inhibitor-1 in Severe COVID-19

Covid19
NCT02829814

Terminated

Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With Fibromyalgia (RE-AFFIRM)

Nervous System Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Muscular Diseases | Neuromuscular Diseases | Fibromyalgia | Myofascial Pain Syndromes
NCT03984110

Completed

One Year Trial Evaluating Safety of Ozurdex With Eylea (COED)

Diabetic Macular Edema
NCT02185820

Completed

Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD) (CPD)

Multiple Myeloma
NCT04808882

Completed

ANTIcoagulation in Severe COVID-19 Patients (ANTICOVID)

Severe COVID-19 Pneumonia
NCT02692339

Completed

Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma (PrObe-L)

Multiple Myeloma
NCT04297839

Suspended

Evaluation of Regional Anticoagulation With Citrate in Extended Hemodialysis

Hemodialysis Complication | Acute Kidney Injury | Anticoagulant Toxicity
NCT01999335

Terminated

A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma

Multiple Myeloma
NCT02101918

Completed

Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery

Pancreatic Neuroendocrine Carcinoma | Multiple Endocrine Neoplasia Type 1
NCT04169269

Unknown

Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban

Deep Vein Thrombosis | Venous Thromboembolism
NCT01647165

Withdrawn

Phase II Study of Subcutaneous (SC) Bortezomib, Lenalidomide and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma; Followed by SC Bortezomib Maintenance

Multiple Myeloma
NCT04185077

Unknown

Bivalirudin in Late PCI for Oatients With STEMI (BETTER)

STEMI - ST Elevation Myocardial Infarction
NCT00555100

Completed

Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma

Multiple Myeloma
NCT02684084

Terminated

Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema (COLLIDE)

Diabetic Macular Edema
NCT02746185

Completed

Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban (CASTA-DIVA)

Venous Thromboembolism | Neoplasm
NCT01510613

Completed

Pomalidomide and Dexamethasone (PDex) in AL Amyloidosis

Primary Amyloidosis of Light Chain Type
NCT01816620

Completed

Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome

POEMS Syndrome
NCT01538095

Completed

Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors

Central Nervous System Neoplasm | Solid Neoplasm
NCT02681536

Unknown

Miniflare Versus Long Protocol in Poor Responders

Infertility
NCT00227591

Completed

Lenalidomide and Prednisone in Treating Patients With Myelofibrosis

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia
NCT01767545

Completed

Dexamethasone-implant for the Treatment of RVO

Macular Edema Caused by Retinal Vein Occlusion
NCT00971685

Unknown

The Treatment of Lenalidomide in Patients With POEMS Syndrome

POEMS Syndrome
NCT04459715

Terminated

A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

Squamous Cell Carcinoma of the Head and Neck
NCT02656121

Completed

Correction of Vitamin D Deficiency and Its Effect on Ovulation Induction in Women With PCOS (VIDEO): A Feasibility RCT (PCOSD)

PCOS
NCT04937699

Recruiting

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention (MATE)

Acute Coronary Syndrome | Percutaneous Coronary Intervention
NCT00059306

Completed

Secondary Prevention of Small Subcortical Strokes Trial (SPS3)

Hypertension | Cerebrovascular Accident
NCT01614509

Completed

Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion
NCT00668863

Completed

Study Of Sunitinib With FOLFIRI In Colorectal Cancer

Unresectable or Metastatic Colorectal Cancer
NCT05962320

Completed

Effect of Modified ERAS Protocol on Clinical Outcomes in Pediatric Patients With Appendectomy

Surgery | Appendicitis | ERAS
NCT06399393

Recruiting

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation (KarMMa-9)

Multiple Myeloma
NCT06290765

Not yet recruiting

Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera (PV)

Polycythemia Vera | Myeloproliferative Neoplasm
NCT06108947

Recruiting

Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks (PEScreenNor)

Pre-Eclampsia
NCT05158062

Recruiting

Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer

Carcinoma, Ovarian Epithelial
NCT04989140

Recruiting

Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide

Multiple Myeloma
NCT04481815

Recruiting

Rituximab Plus Methotrexate With or Without Lenalidomide in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

PCNSL
NCT04307511

Recruiting

A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients (TIGER-diabetes)

Acute Coronary Syndrome Patients With Diabetes After PCI
NCT04181749

Recruiting

Peri-vascular Adipose Tissue Inflammation Evaluated Using Coronary CT Angiography (P-VECT)

Cardiovascular Risk Factor
NCT03431142

Completed

Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial (OPT-BIRISK)

Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage
NCT04052880

Active, not recruiting

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM

Newly Diagnosed Multiple Myeloma
NCT05330429

Terminated

Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) (ELEVATE CRC)

Metastatic Colorectal Cancer
NCT04952753

Terminated

Study of NIS793 and Other Novel Investigational Combinations With SOC Anti-cancer Therapy for the 2L Treatment of mCRC (daNIS-3)

Metastatic Colorectal Cancer
NCT01894061

Completed

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Recurrent Adult Brain Tumor
NCT02733042

Completed

A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia (FUSION NHL 001)

Lymphoma | Leukemia, Lymphocytic, Chronic, B-Cell
NCT00305812

Completed

Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations